Clinical trials: AIDS-Related Primary Effusion Lymphoma
Lymphoma
Combination Chemotherapy in Treating Patients With AIDS-Related Hodgkin's Disease
RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. Combining more than one drug may kill more tumor cells.
- Trial name
- NCT00003114
- Testing
- filgrastim, cyclophosphamide, etoposide
- Where
- United States
- Volunteers
- 5 people
- Sponsor
- Case Comprehensive Cancer Center
Lymphoma
Combination Chemotherapy in Treating Patients With AIDS-Related Lymphoma
RATIONALE: Drugs used in chemotherapy use different ways to stop cancer cells from dividing so they stop growing or die. Combining more than one drug may kill more cancer cells.
- Trial name
- NCT00002524
- Testing
- Bleomycin Sulfate, Filgrastim, Cisplatin
- Where
- 2 sites in United States
- Volunteers
- 46 people
- Sponsor
- M.D. Anderson Cancer Center
Lymphoma
Peripheral Stem Cell Transplantation Followed By Infusion of White Blood Cells in Treating Patients With AIDS-Related Lymphoma
RATIONALE: Donor peripheral stem cell transplantation may be able to replace immune cells that were destroyed by chemotherapy or radiation therapy. Sometimes the transplanted cells are rejected by the body's normal tissues.
- Trial name
- NCT00024128
- Testing
- anti-thymocyte globulin, therapeutic allogeneic lymphocytes, cyclophosphamide
- Sponsor
- AIDS Malignancy Consortium